APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Injection Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oncology Injection Drug Industry Growth and Trends Forecast to 2032

26 December 2025115 pages

Choose your research edition.

Industry ResearchOncology Injection Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Injection Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Oncology Injection Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Injection Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Injection Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oncology Injection Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oncology Injection Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oncology Injection Drug include AdvaCare, Allos Therapeutics, Alza, Celgene, CordenPharma, Debiopharm, Ferring Pharmaceuticals, Genzyme and Merrimack, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oncology Injection Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oncology Injection Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oncology Injection Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oncology Injection Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oncology Injection Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oncology Injection Drug Market by Company

AdvaCare

Allos Therapeutics

Alza

Celgene

CordenPharma

Debiopharm

Ferring Pharmaceuticals

Genzyme

Merrimack

Millennium Pharmaceuticals

Pharmascience

Praecis Pharmaceuticals

S.G. Biopharm

Taj Oncology

Eli Lilly

Oncology Injection Drug Segment by Type

Central Nervous System

Circulatory/Musculoskeletal System

Organs

Other

Oncology Injection Drug Segment by Application

Myeloma

Lymphoma

Prostate Cancer

Other

Oncology Injection Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Injection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Injection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Injection Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oncology Injection Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Central Nervous System Table 2. Major Company of Circulatory/Musculoskeletal System Table 3. Major Company of Organs Table 4. Major Company of Other Table 5. Global Oncology Injection Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Oncology Injection Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oncology Injection Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Oncology Injection Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Oncology Injection Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oncology Injection Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oncology Injection Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Oncology Injection Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Oncology Injection Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Oncology Injection Drug Industry Trends Table 27. Oncology Injection Drug Industry Drivers Table 28. Oncology Injection Drug Industry Opportunities and Challenges Table 29. Oncology Injection Drug Industry Restraints Table 30. Global Oncology Injection Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oncology Injection Drug Revenue Market Share by Company (2021-2026) Table 32. Global Oncology Injection Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Oncology Injection Drug Sales Share by Company (2021-2026) Table 34. Global Oncology Injection Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Oncology Injection Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oncology Injection Drug Major Company Production Sites and Headquarters Table 37. Global Oncology Injection Drug Company, Product Type & Application Table 38. Global Oncology Injection Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oncology Injection Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oncology Injection Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Oncology Injection Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oncology Injection Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oncology Injection Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Oncology Injection Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Oncology Injection Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Oncology Injection Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oncology Injection Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oncology Injection Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Oncology Injection Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Oncology Injection Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Oncology Injection Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oncology Injection Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Oncology Injection Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Oncology Injection Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oncology Injection Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oncology Injection Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Oncology Injection Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Oncology Injection Drug Sales by Application (2021-2026) & (US$ Million) Table 73. AdvaCare Company Information Table 74. AdvaCare Business Overview Table 75. AdvaCare Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AdvaCare Oncology Injection Drug Product Portfolio Table 77. AdvaCare Recent Development Table 78. Allos Therapeutics Company Information Table 79. Allos Therapeutics Business Overview Table 80. Allos Therapeutics Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Allos Therapeutics Oncology Injection Drug Product Portfolio Table 82. Allos Therapeutics Recent Development Table 83. Alza Company Information Table 84. Alza Business Overview Table 85. Alza Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Alza Oncology Injection Drug Product Portfolio Table 87. Alza Recent Development Table 88. Celgene Company Information Table 89. Celgene Business Overview Table 90. Celgene Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Celgene Oncology Injection Drug Product Portfolio Table 92. Celgene Recent Development Table 93. CordenPharma Company Information Table 94. CordenPharma Business Overview Table 95. CordenPharma Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. CordenPharma Oncology Injection Drug Product Portfolio Table 97. CordenPharma Recent Development Table 98. Debiopharm Company Information Table 99. Debiopharm Business Overview Table 100. Debiopharm Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Debiopharm Oncology Injection Drug Product Portfolio Table 102. Debiopharm Recent Development Table 103. Ferring Pharmaceuticals Company Information Table 104. Ferring Pharmaceuticals Business Overview Table 105. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio Table 107. Ferring Pharmaceuticals Recent Development Table 108. Genzyme Company Information Table 109. Genzyme Business Overview Table 110. Genzyme Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Genzyme Oncology Injection Drug Product Portfolio Table 112. Genzyme Recent Development Table 113. Merrimack Company Information Table 114. Merrimack Business Overview Table 115. Merrimack Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Merrimack Oncology Injection Drug Product Portfolio Table 117. Merrimack Recent Development Table 118. Millennium Pharmaceuticals Company Information Table 119. Millennium Pharmaceuticals Business Overview Table 120. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio Table 122. Millennium Pharmaceuticals Recent Development Table 123. Pharmascience Company Information Table 124. Pharmascience Business Overview Table 125. Pharmascience Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Pharmascience Oncology Injection Drug Product Portfolio Table 127. Pharmascience Recent Development Table 128. Praecis Pharmaceuticals Company Information Table 129. Praecis Pharmaceuticals Business Overview Table 130. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio Table 132. Praecis Pharmaceuticals Recent Development Table 133. S.G. Biopharm Company Information Table 134. S.G. Biopharm Business Overview Table 135. S.G. Biopharm Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. S.G. Biopharm Oncology Injection Drug Product Portfolio Table 137. S.G. Biopharm Recent Development Table 138. Taj Oncology Company Information Table 139. Taj Oncology Business Overview Table 140. Taj Oncology Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Taj Oncology Oncology Injection Drug Product Portfolio Table 142. Taj Oncology Recent Development Table 143. Eli Lilly Company Information Table 144. Eli Lilly Business Overview Table 145. Eli Lilly Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Eli Lilly Oncology Injection Drug Product Portfolio Table 147. Eli Lilly Recent Development Table 148. North America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. North America Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 150. North America Oncology Injection Drug Sales Market Share by Country (2021-2026) Table 151. North America Oncology Injection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 152. North America Oncology Injection Drug Sales Market Share Forecast by Country (2027-2032) Table 153. North America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Oncology Injection Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Oncology Injection Drug Market Share by Country (2021-2026) Table 156. North America Oncology Injection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Oncology Injection Drug Market Share Forecast by Country (2027-2032) Table 158. Europe Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Europe Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 160. Europe Oncology Injection Drug Sales Market Share by Country (2021-2026) Table 161. Europe Oncology Injection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 162. Europe Oncology Injection Drug Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Oncology Injection Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Oncology Injection Drug Market Share by Country (2021-2026) Table 166. Europe Oncology Injection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Oncology Injection Drug Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 170. Asia-Pacific Oncology Injection Drug Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Oncology Injection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 172. Asia-Pacific Oncology Injection Drug Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Oncology Injection Drug Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Oncology Injection Drug Market Share by Country (2021-2026) Table 176. Asia-Pacific Oncology Injection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Oncology Injection Drug Market Share Forecast by Country (2027-2032) Table 178. Latin America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Latin America Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 180. Latin America Oncology Injection Drug Sales Market Share by Country (2021-2026) Table 181. Latin America Oncology Injection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 182. Latin America Oncology Injection Drug Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Oncology Injection Drug Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Oncology Injection Drug Market Share by Country (2021-2026) Table 186. Latin America Oncology Injection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Oncology Injection Drug Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 190. Middle East and Africa Oncology Injection Drug Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Oncology Injection Drug Sales Forecast by Country (2027-2032) & (K Units) Table 192. Middle East and Africa Oncology Injection Drug Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Oncology Injection Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Oncology Injection Drug Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Oncology Injection Drug Market Share by Country (2021-2026) Table 196. Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Oncology Injection Drug Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Oncology Injection Drug Distributors List Table 201. Oncology Injection Drug Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Oncology Injection Drug Image Figure 2. Global Oncology Injection Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology Injection Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oncology Injection Drug Sales (2021-2032) & (K Units) Figure 5. Central Nervous System Image Figure 6. Global Central Nervous System Sales YoY Growth (2021-2032) & (K Units) Figure 7. Circulatory/Musculoskeletal System Image Figure 8. Global Circulatory/Musculoskeletal System Sales YoY Growth (2021-2032) & (K Units) Figure 9. Organs Image Figure 10. Global Organs Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Oncology Injection Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oncology Injection Drug Market Share by Type 2025 VS 2032 Figure 15. North America Oncology Injection Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Oncology Injection Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Oncology Injection Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oncology Injection Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oncology Injection Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oncology Injection Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oncology Injection Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oncology Injection Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Myeloma Image Figure 28. Global Myeloma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Lymphoma Image Figure 30. Global Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Prostate Cancer Image Figure 32. Global Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Oncology Injection Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Oncology Injection Drug Market Share by Application 2025 VS 2032 Figure 37. North America Oncology Injection Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Oncology Injection Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Oncology Injection Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Oncology Injection Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Oncology Injection Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Oncology Injection Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Oncology Injection Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Oncology Injection Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Oncology Injection Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Oncology Injection Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Oncology Injection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Oncology Injection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Oncology Injection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Oncology Injection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oncology Injection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Oncology Injection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Oncology Injection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Oncology Injection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oncology Injection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Oncology Injection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Oncology Injection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Oncology Injection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oncology Injection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Oncology Injection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oncology Injection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Oncology Injection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oncology Injection Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Oncology Injection Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Oncology Injection Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Oncology Injection Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Oncology Injection Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Oncology Injection Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Central Nervous System
  • Circulatory/Musculoskeletal System
  • Organs
  • Other
Applications
  • Myeloma
  • Lymphoma
  • Prostate Cancer
  • Other
Companies covered
  • AdvaCare
  • Allos Therapeutics
  • Alza
  • Celgene
  • CordenPharma
  • Debiopharm
  • Ferring Pharmaceuticals
  • Genzyme
  • Merrimack
  • Millennium Pharmaceuticals
  • Pharmascience
  • Praecis Pharmaceuticals
  • S.G. Biopharm
  • Taj Oncology
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oncology Injection Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oncology Injection Drug Market by Type
  6. 1.3.1 Central Nervous System
  7. 1.3.2 Circulatory/Musculoskeletal System
  8. 1.3.3 Organs
  9. 1.3.4 Other
  10. 1.4 Global Oncology Injection Drug Market Size by Type
  11. 1.4.1 Global Oncology Injection Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oncology Injection Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oncology Injection Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oncology Injection Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oncology Injection Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oncology Injection Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oncology Injection Drug Industry Trends
  2. 2.2 Oncology Injection Drug Industry Drivers
  3. 2.3 Oncology Injection Drug Industry Opportunities and Challenges
  4. 2.4 Oncology Injection Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oncology Injection Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Oncology Injection Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Oncology Injection Drug Price (2021-2026)
  4. 3.4 Global Oncology Injection Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oncology Injection Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Oncology Injection Drug Company, Product Type & Application
  7. 3.7 Global Oncology Injection Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oncology Injection Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oncology Injection Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oncology Injection Drug Tier 1, Tier 2, and Tier 3
4 Oncology Injection Drug Regional Status and Outlook
  1. 4.1 Global Oncology Injection Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oncology Injection Drug Historic Market Size by Region
  3. 4.2.1 Global Oncology Injection Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oncology Injection Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oncology Injection Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oncology Injection Drug Forecasted Market Size by Region
  7. 4.3.1 Global Oncology Injection Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oncology Injection Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oncology Injection Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oncology Injection Drug by Application
  1. 5.1 Oncology Injection Drug Market by Application
  2. 5.1.1 Myeloma
  3. 5.1.2 Lymphoma
  4. 5.1.3 Prostate Cancer
  5. 5.1.4 Other
  6. 5.2 Global Oncology Injection Drug Market Size by Application
  7. 5.2.1 Global Oncology Injection Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Oncology Injection Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Oncology Injection Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Oncology Injection Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Oncology Injection Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Oncology Injection Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Oncology Injection Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Oncology Injection Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AdvaCare
  2. 6.1.1 AdvaCare Company Information
  3. 6.1.2 AdvaCare Business Overview
  4. 6.1.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AdvaCare Oncology Injection Drug Product Portfolio
  6. 6.1.5 AdvaCare Recent Developments
  7. 6.2 Allos Therapeutics
  8. 6.2.1 Allos Therapeutics Company Information
  9. 6.2.2 Allos Therapeutics Business Overview
  10. 6.2.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
  12. 6.2.5 Allos Therapeutics Recent Developments
  13. 6.3 Alza
  14. 6.3.1 Alza Company Information
  15. 6.3.2 Alza Business Overview
  16. 6.3.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Alza Oncology Injection Drug Product Portfolio
  18. 6.3.5 Alza Recent Developments
  19. 6.4 Celgene
  20. 6.4.1 Celgene Company Information
  21. 6.4.2 Celgene Business Overview
  22. 6.4.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Celgene Oncology Injection Drug Product Portfolio
  24. 6.4.5 Celgene Recent Developments
  25. 6.5 CordenPharma
  26. 6.5.1 CordenPharma Company Information
  27. 6.5.2 CordenPharma Business Overview
  28. 6.5.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CordenPharma Oncology Injection Drug Product Portfolio
  30. 6.5.5 CordenPharma Recent Developments
  31. 6.6 Debiopharm
  32. 6.6.1 Debiopharm Company Information
  33. 6.6.2 Debiopharm Business Overview
  34. 6.6.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Debiopharm Oncology Injection Drug Product Portfolio
  36. 6.6.5 Debiopharm Recent Developments
  37. 6.7 Ferring Pharmaceuticals
  38. 6.7.1 Ferring Pharmaceuticals Company Information
  39. 6.7.2 Ferring Pharmaceuticals Business Overview
  40. 6.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
  42. 6.7.5 Ferring Pharmaceuticals Recent Developments
  43. 6.8 Genzyme
  44. 6.8.1 Genzyme Company Information
  45. 6.8.2 Genzyme Business Overview
  46. 6.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genzyme Oncology Injection Drug Product Portfolio
  48. 6.8.5 Genzyme Recent Developments
  49. 6.9 Merrimack
  50. 6.9.1 Merrimack Company Information
  51. 6.9.2 Merrimack Business Overview
  52. 6.9.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merrimack Oncology Injection Drug Product Portfolio
  54. 6.9.5 Merrimack Recent Developments
  55. 6.10 Millennium Pharmaceuticals
  56. 6.10.1 Millennium Pharmaceuticals Company Information
  57. 6.10.2 Millennium Pharmaceuticals Business Overview
  58. 6.10.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
  60. 6.10.5 Millennium Pharmaceuticals Recent Developments
  61. 6.11 Pharmascience
  62. 6.11.1 Pharmascience Company Information
  63. 6.11.2 Pharmascience Business Overview
  64. 6.11.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pharmascience Oncology Injection Drug Product Portfolio
  66. 6.11.5 Pharmascience Recent Developments
  67. 6.12 Praecis Pharmaceuticals
  68. 6.12.1 Praecis Pharmaceuticals Company Information
  69. 6.12.2 Praecis Pharmaceuticals Business Overview
  70. 6.12.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
  72. 6.12.5 Praecis Pharmaceuticals Recent Developments
  73. 6.13 S.G. Biopharm
  74. 6.13.1 S.G. Biopharm Company Information
  75. 6.13.2 S.G. Biopharm Business Overview
  76. 6.13.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
  78. 6.13.5 S.G. Biopharm Recent Developments
  79. 6.14 Taj Oncology
  80. 6.14.1 Taj Oncology Company Information
  81. 6.14.2 Taj Oncology Business Overview
  82. 6.14.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Taj Oncology Oncology Injection Drug Product Portfolio
  84. 6.14.5 Taj Oncology Recent Developments
  85. 6.15 Eli Lilly
  86. 6.15.1 Eli Lilly Company Information
  87. 6.15.2 Eli Lilly Business Overview
  88. 6.15.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Eli Lilly Oncology Injection Drug Product Portfolio
  90. 6.15.5 Eli Lilly Recent Developments
7 North America by Country
  1. 7.1 North America Oncology Injection Drug Sales by Country
  2. 7.1.1 North America Oncology Injection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oncology Injection Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Oncology Injection Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oncology Injection Drug Market Size by Country
  6. 7.2.1 North America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oncology Injection Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Oncology Injection Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oncology Injection Drug Sales by Country
  2. 8.1.1 Europe Oncology Injection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oncology Injection Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Oncology Injection Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oncology Injection Drug Market Size by Country
  6. 8.2.1 Europe Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oncology Injection Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oncology Injection Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oncology Injection Drug Sales by Country
  2. 9.1.1 Asia-Pacific Oncology Injection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oncology Injection Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oncology Injection Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oncology Injection Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oncology Injection Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oncology Injection Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oncology Injection Drug Sales by Country
  2. 10.1.1 South America Oncology Injection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oncology Injection Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Oncology Injection Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oncology Injection Drug Market Size by Country
  6. 10.2.1 South America Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oncology Injection Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Oncology Injection Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oncology Injection Drug Sales by Country
  2. 11.1.1 Middle East and Africa Oncology Injection Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oncology Injection Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oncology Injection Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oncology Injection Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Oncology Injection Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oncology Injection Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oncology Injection Drug Value Chain Analysis
  2. 12.1.1 Oncology Injection Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oncology Injection Drug Production Mode & Process
  7. 12.2 Oncology Injection Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oncology Injection Drug Distributors
  10. 12.2.3 Oncology Injection Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst